Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;141(8):1749-55.
doi: 10.1017/S0950268812002178. Epub 2012 Sep 25.

Trimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study

Affiliations

Trimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study

J T Andersen et al. Epidemiol Infect. 2013 Aug.

Abstract

The antibiotic trimethoprim acts as a folate antagonist. Since trophoblasts are very sensitive to drugs that interfere with the folic acid cycle and thereby inhibit DNA synthesis, use of trimethoprim during the first trimester could be associated with miscarriage. A nationwide cohort study including all women in Denmark with a registered pregnancy between 1997 and 2005 was conducted. We used nationwide registers to identify all women giving birth, having a record of miscarriage or induced abortion. Data on exposure to trimethoprim were obtained from the National Prescription Register. Cox proportional hazard regression analysis with exposure to trimethoprim as a time-dependent variable was used to estimate the risk of miscarriage. The adjusted hazard ratio of having a miscarriage after exposure to trimethoprim in the first trimester compared to non-exposure was 2∙04 (95% confidence interval 1∙43-2∙91). Our results indicate that trimethoprim exposure in the first trimester is associated with a doubling of the hazard of miscarriage.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Hazard ratio for miscarriage following trimethoprim exposure in three different parts of the first trimester.

References

    1. Schweitzer BI, Dicker AP, Bertino JR. Dihydrofolate-reductase as a therapeutic target. FASEB Journal 1990; 4: 2441–2452. - PubMed
    1. Baird DT. Mode of action of medical methods of abortion. Journal of the American Medical Womens Association 2000; 55: 121–126. - PubMed
    1. Hernandez-Diaz S, et al. Folic acid antagonists during pregnancy and the risk of birth defects. New England Journal of Medicine 2000; 343: 1608–1614. - PubMed
    1. Hernandez-Diaz S, et al. Neural tube defects in relation to use of folic acid antagonists during pregnancy. American Journal of Epidemiology 2001; 153: 961–968. - PubMed
    1. Czeizel AE, Toth M, Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996; 53: 345–351. - PubMed